Sign inJoin waitlistJoin the waitlist

Herbert Bonkovsky

Director, Gastroenterology, Internal Medicine · Wake Forest University Baptist Medical Center

Credentials: · · · · ·

History

Wake Forest University Baptist Medical Center
Present

Yale University
1971–1974
Cleveland Metropolitan Genl Hospital
1968–1969
Internal Medicine
Duke University Hospital
1967–1968
Case Western Reserve Univ Sch of Med
1963–1967

Research

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
Nature Genetics · 2013 · 786 citations
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
Gastroenterology · 2015 · 708 citations
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States
Gastroenterology · 2008 · 650 citations

Robert Fontana
53 papers
William Lee
35 papers
Adrian Di Bisceglie
32 papers
Karl Anderson
30 papers
MG
Marc Ghany
30 papers
BB
Barbara Banner
28 papers
JD
Jules Dienstag
28 papers
Timothy Morgan
28 papers
Anna Lok
27 papers
Chihiro Morishima
25 papers
Naga Chalasani
25 papers
KL
Karen Lindsay
24 papers

Grants

Effect of Heme on mRNA and miRNA Profile
National Heart, Lung, and Blood Institute · R15
Contact PI · $431.9K · Winston-Salem State University
2013–2016
Regulation of Hepatic Heme Metabolism
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $6.7M · Carolinas Medical Center
1987–2011
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $229.9K · University of Connecticut Sch of Med/Dnt
2004–2009
Research Network for Drug-Induced Liver Disease
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $950.2K · University of Connecticut Sch of Med/Dnt
2003–2008

Clinical trials

Effect of Bitopertin on the Liver and on Levels of Protoporphyrin IX in Bile, Blood, Liver, and Stool in Patients With Erythropoietic Protoporphyria/X-linked Protoporphyria and Increased Liver Stiffness and/or Liver Enzymes at Baseline
Principal investigator · Withdrawn · Phase 1
Wake Forest University Health Sciences
2026–2035
Clinical Diagnosis of Acute Porphyria
Principal investigator · Completed
University of California, San Francisco
2011–2018
Harvoni Treatment Porphyria Cutanea Tarda
Study chair · Completed · Phase 2
Wake Forest University Health Sciences
2017–2022